Nisa Investment Advisors’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Buy |
2,391
+1,429
| +149% | +$76.3K | ﹤0.01% | 1322 |
|
|
2025
Q1 | $38.9K | Buy |
962
+2
| +0.2% | +$81 | ﹤0.01% | 1664 |
|
|
2024
Q4 | $26.7K | Buy |
960
+174
| +22% | +$4.84K | ﹤0.01% | 1851 |
|
|
2024
Q3 | $22.6K | Buy |
786
+24
| +3% | +$689 | ﹤0.01% | 1878 |
|
|
2024
Q2 | $17.9K | Buy |
762
+372
| +95% | +$8.73K | ﹤0.01% | 1986 |
|
|
2024
Q1 | $9.85K | Buy |
390
+70
| +22% | +$1.77K | ﹤0.01% | 2036 |
|
|
2023
Q4 | $7.47K | Sell |
320
-660
| -67% | -$15.4K | ﹤0.01% | 2078 |
|
|
2023
Q3 | $49.6K | Buy |
980
+300
| +44% | +$15.2K | ﹤0.01% | 1729 |
|
|
2023
Q2 | $31.7K | Buy |
680
+179
| +36% | +$8.36K | ﹤0.01% | 1916 |
|
|
2023
Q1 | $19K | Sell |
501
-102,520
| -100% | -$3.89M | ﹤0.01% | 2019 |
|
|
2022
Q4 | $5.65M | Buy |
103,021
+103,000
| +490,476% | +$5.64M | 0.04% | 392 |
|
|
2022
Q3 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 2384 |
|